1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Ubunyulu >98.0% (HPLC) Brexpiprazole Intermediate Factory

Inkcazelo emfutshane:

1-(1-Benzothiophen-4-yl) piperazine Hydrochloride

CAS: 913614-18-3

Ubunyulu: >99.0% (HPLC)

Imbonakalo: Mhlophe ukuya kwi-Off-White Powder

Umbindi weBrexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza 1-(1-Benzothiophen-4-yl) piperazine Hydrochloride
Izithethantonye I-Brexpiprazole ePhakathi 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;I-1-Benzo[b]thien-4-ylpiperazine Monohydrochloride
Inombolo yeCAS 913614-18-3
Inombolo yeCAT RF-PI1034
Ubume beStokhwe Kwi-Stock, iMveliso yeMveliso ye-100MT/Unyaka
Ifomula yeemolekyuli I-C12H15ClN2S
Ubunzima beMolekyuli 254.7789
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Mhlophe ukuya kwi-Off-White Powder
Ukuchongwa Ixesha lokugcinwa kwesampulu lihambelana nelo lomgangatho wereferensi
Ubunyulu / Indlela yokuHlalutya >99.0% (HPLC)
Ilahleko ekomisweni <0.50%
Amanzi (KF) <0.50%
Intsalela kwi-Ignition <0.20%
Izinto ezinxulumeneyo (HPLC)
Nakuphi na Ukungacoceki komntu <0.50%
Ukungcola ngokupheleleyo <1.00%
I-Infrared Spectrum Iyahambelana noLwakhiwo
Proton NMR Spectrum Iyahambelana noLwakhiwo
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Umbindi weBrexpiprazole (CAS: 913611-97-9)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-1-(1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) iphakathi kweBrexpiprazole (CAS: 913611-97-9).I-Brexpiprazole luhlobo lwe-antipsychotic engabonakaliyo.Yi-dopamine D2 receptor partial agonist.Njengenoveli yemodyuli ye-serotonin-dopamine, inokusetyenziselwa unyango lwe-schizophrenia, kunye nonyango olongezelelweyo loxinzelelo.Inokubonelela ngokusebenza kunye nokunyamezeleka ngaphezu konyango olumiselweyo olunxulumene noxinzelelo olukhulu (MDD).Ichiza libonisa iphrofayili ekhethekileyo ye-pharmacological, esebenza njenge-agonist inxalenye ye-serotonin 5-HT1A kunye ne-dopamine D2 receptors kunye ne-antagonist epheleleyo ye-5-HT2A kunye ne-noradrenaline α1B / 2C i-receptors, kunye ne-subnanomolar efanayo ebophelelayo.Ichiza, elaphuhliswa ngu-Otsuka kunye no-Lundbeck, livunyiwe kwi-2015 yi-FDA yonyango lwe-schizophrenia kunye nonyango lokuncedisa ukudakumba.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi